Health and Happiness (H&H) International Holdings Ltd
HKEX:1112
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Health and Happiness (H&H) International Holdings Ltd
HKEX:1112
|
HK |
|
Aoxing Pharmaceutical Company Inc
OTC:AOXG
|
US |
|
Geomatec Co Ltd
TSE:6907
|
JP |
|
P
|
Planet Fitness Inc
F:3PL
|
US |
|
Akeso Inc
HKEX:9926
|
CN |
Health and Happiness (H&H) International Holdings Ltd
Health & Happiness (H&H) International Holdings Ltd. engages in the manufacture and sale of pediatric nutritional and baby care products. The company employs 3,315 full-time employees The company went IPO on 2010-12-17. The firm operates through five business segments. The Infant Formulas segment is engaged in the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment is engaged in the production of vitamins, health supplements, skin care and sports nutrition products for adults. The Probiotic Supplements segment is engaged in the production of probiotic supplements. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods, as well as microencapsulated milk calcium chewable tablets. The Baby Care Products segment is engaged in the production of baby care products.
Health & Happiness (H&H) International Holdings Ltd. engages in the manufacture and sale of pediatric nutritional and baby care products. The company employs 3,315 full-time employees The company went IPO on 2010-12-17. The firm operates through five business segments. The Infant Formulas segment is engaged in the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment is engaged in the production of vitamins, health supplements, skin care and sports nutrition products for adults. The Probiotic Supplements segment is engaged in the production of probiotic supplements. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods, as well as microencapsulated milk calcium chewable tablets. The Baby Care Products segment is engaged in the production of baby care products.
Revenue Growth: H&H International reported first-half 2025 revenue of over RMB 7 billion, growing 4.9% year-on-year, with all three business segments (ANC, BNC, PNC) showing positive growth.
Profitability: EBITDA margin was maintained at a healthy 15.7%, and adjusted net profit grew 4.6% to RMB 363 million, with a 5.2% margin.
Segment Highlights: ANC business led growth, rising 5.9% overall and 13% in Mainland China where Swisse became the #1 brand. BNC (IMF) grew 10%, and PNC (pet nutrition) grew 8.6%.
Channel & Geography: China is the largest market (70% of revenue), with strong growth in IMF, pet nutrition, and nutritional products. Expansion markets grew 18.6%. ANZ local market grew single digits, offsetting Daigou channel declines.
Guidance Affirmed: Management reiterated full-year guidance for high single-digit revenue growth, ~15% EBITDA margin, and ~5% adjusted net profit margin.
Dividend & Refinancing: Interim dividend of HKD 0.19/share announced. Completed USD 300 million refinancing, expected to lower interest costs and leverage.
Future Focus: Continued investment in product innovation, channel diversification, and premiumization across markets. Management confident in meeting full-year targets.
